Medpace Holdings (MEDP) Share-based Compensation (2015 - 2026)

Medpace Holdings has reported Share-based Compensation for 12 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 70.89% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $22.8 million (down 40.12% YoY), and the FY2025 full-year result was $34.8 million, up 36.34% from the prior year.
• Share-based Compensation for Q1 2026 stood at $4.9 million, down from $5.6 million in the prior quarter.
• The five-year high for Share-based Compensation was $16.9 million in Q1 2025, with the low at $3.6 million in Q2 2024.
• Historically, Share-based Compensation has averaged $6.3 million across 5 years, with a median of $5.6 million in 2022.
• Annual changes were most pronounced in 2025 — Share-based Compensation jumped 291.93% — and 2026, when it sank 70.89%.
• Medpace Holdings' Share-based Compensation stood at $5.6 million in 2022, then slipped by 7.65% to $5.2 million in 2023, then climbed by 14.02% to $5.9 million in 2024, then fell by 4.57% to $5.6 million in 2025, then retreated by 12.49% to $4.9 million in 2026.
• The last three Share-based Compensation figures came in at $4.9 million (Q1 2026), $5.6 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.